COMBINATION OF TUMOR NECROSIS FACTOR (TNF) ANTAGONISTS AND COX-2 INHIBITORS FOR THE TREATMENT OF INFLAMMATION - Patent 1189628

(19)

(11)

EP 1 189 628 A1

(12)

(43)	Date of publication:
	27.03.2002 Bulletin 2002/13

(21)	Application number: 00944668.3

(22)	Date of filing: 26.06.2000

(51)	International Patent Classification (IPC)⁷: A61K 38/19, A61K 31/63

(86)	International application number:
	PCT/US0016/292

(87)	International publication number:
	WO 0100/229 (04.01.2001 Gazette 2001/01)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

24.06.1999 US 141238 P

(71)	Applicant: Pharmacia Corporation
	Chicago, IL 60680-5110 (US)

(72)	Inventor:
	KEANE, J., Timothy Clayton, MO 63105 (US)

(74)	Representative: Albrecht, Thomas, Dr. et al
	Kraus & Weisert,Thomas-Wimmer-Ring 15 80539 München 80539 München (DE)

(54)	COMBINATION OF TUMOR NECROSIS FACTOR (TNF) ANTAGONISTS AND COX-2 INHIBITORS FOR THE TREATMENT OF INFLAMMATION